{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:17:38Z","timestamp":1789690658901,"version":"4.0.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jaad.2014.05.007","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T22:30:34Z","timestamp":1413325834000},"page":"847.e1-847.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Polycystic ovary syndrome: A review for dermatologists"],"prefix":"10.1016","volume":"71","author":[{"given":"Elizabeth","family":"Housman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel V.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.05.007_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral\u00a0polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2014.05.007_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2014.05.007_bib3","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib4","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and\u00a0association with metabolic factors","volume":"113","author":"Broekmans","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.jaad.2014.05.007_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jaad.2014.05.007_bib6","first-page":"238","article-title":"The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria","volume":"62","author":"Mehrabian","year":"2011","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.jaad.2014.05.007_bib7","first-page":"1328","article-title":"Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women","volume":"79","author":"Barnes","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0015-0282(01)02947-8","article-title":"Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess","volume":"77","author":"Eisner","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2014.05.007_bib9","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1210\/endo.140.12.7205","article-title":"In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone","volume":"140","author":"Robinson","year":"1999","journal-title":"Endocrinology"},{"issue":"suppl 5","key":"10.1016\/j.jaad.2014.05.007_bib10","first-page":"1303","article-title":"Family history as a risk factor for the polycystic ovary syndrome","volume":"13","author":"Azziz","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib11","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2014.05.007_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/0022-3859.40778","article-title":"Present status of understanding on the genetic etiology of polycystic ovary syndrome","volume":"54","author":"Dasgupta","year":"2008","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.jaad.2014.05.007_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib14","first-page":"4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"Eagleson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 2","key":"10.1016\/j.jaad.2014.05.007_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/humrep\/8.suppl_2.123","article-title":"Hypersecretion of luteinizing hormone and the polycystic ovary syndrome","volume":"8","author":"Balen","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jaad.2014.05.007_bib16","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women","volume":"10","author":"Clark","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jaad.2014.05.007_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2014.05.007_bib18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/humrep\/dem391","article-title":"Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study","volume":"23","author":"Palomba","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jaad.2014.05.007_bib19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.fertnstert.2013.11.027","article-title":"Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome","volume":"101","author":"Sung","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2014.05.007_bib20","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups","volume":"83","author":"Chang","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2014.05.007_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity of the\u00a0polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients","volume":"30","author":"Conway","year":"1989","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jaad.2014.05.007_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","article-title":"Hirsutism and acne in polycystic ovary syndrome","volume":"18","author":"Archer","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jaad.2014.05.007_bib23","first-page":"275","article-title":"Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences","volume":"16","author":"Falsetti","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jaad.2014.05.007_bib24","first-page":"840","article-title":"Responses of serum gonadotrophins to LH-releasing hormone and oestrogens in Japanese women with polycystic ovaries","volume":"85","author":"Aono","year":"1977","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.jaad.2014.05.007_bib25","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does\u00a0ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2014.05.007_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.2002.01603.x","article-title":"Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?","volume":"57","author":"Wijeyaratne","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jaad.2014.05.007_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/00015550410023248","article-title":"Correlation between endocrinological parameters and acne severity in adult women","volume":"84","author":"Borgia","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2014.05.007_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1346-8138.1997.tb02778.x","article-title":"Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne","volume":"24","author":"Timpatanapong","year":"1997","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2014.05.007_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000067823","article-title":"Update and future of hormonal therapy in acne","volume":"206","author":"Thiboutot","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2014.05.007_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","article-title":"Role of hormones in pilosebaceous unit development","volume":"21","author":"Deplewski","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaad.2014.05.007_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.beem.2006.02.004","article-title":"Diagnosis of hyperandrogenism: clinical criteria","volume":"20","author":"Yildiz","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3 suppl","key":"10.1016\/j.jaad.2014.05.007_bib33","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2001.117426","article-title":"Female pattern hair loss","volume":"45","author":"Olsen","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.05.007_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0002-9378(16)37277-5","article-title":"The Stein-Leventhal syndrome: analysis of 43 cases with special reference to association with endometrial carcinoma","volume":"73","author":"Dockerty","year":"1957","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2014.05.007_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beem.2006.03.005","article-title":"Endometrium in PCOS: Implantation and predisposition to endocrine CA","volume":"20","author":"Giudice","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jaad.2014.05.007_bib37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries\u2014a common finding in normal women","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2014.05.007_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1479-828X.1994.tb01041.x","article-title":"The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women","volume":"34","author":"Farquhar","year":"1994","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jaad.2014.05.007_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2014.05.007_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2265.2000.00884.x","article-title":"The prevalence of polycystic ovaries in women with type 2 diabetes mellitus","volume":"52","author":"Conn","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jaad.2014.05.007_bib41","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2003-031600","article-title":"Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome","volume":"89","author":"Adams","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","author":"Dokras","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2014.05.007_bib43","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.fertnstert.2013.10.055","article-title":"Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women without PCOS","volume":"101","author":"Hillman","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2014.05.007_bib44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib45","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib46","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib47","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/jc.2003-031720","article-title":"Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study","volume":"89","author":"Taponen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"Lim","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.jaad.2014.05.007_bib49","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.jaad.2014.05.007_bib50","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2014.05.007_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/01443615.2012.745839","article-title":"Effects of low-dose metformin and\u00a0rosiglitazone on biochemical, clinical, metabolic and biophysical outcomes in polycystic ovary syndrome","volume":"33","author":"Mohiyiddeen","year":"2013","journal-title":"J Obstet Gynaecol"},{"issue":"6 suppl","key":"10.1016\/j.jaad.2014.05.007_bib53","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1111\/1523-1747.ep12462293","article-title":"Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans","volume":"98","author":"Cruz","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2014.05.007_bib54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","article-title":"Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia","volume":"65","author":"Dunaif","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/humrep\/16.3.556","article-title":"Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population","volume":"16","author":"Elting","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jaad.2014.05.007_bib56","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2007-1756","article-title":"A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study","volume":"93","author":"Valkenburg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1067\/mob.2002.119180","article-title":"Polycystic ovary syndrome: a risk for coronary artery disease?","volume":"186","author":"Wild","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2014.05.007_bib58","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jaad.2014.05.007_bib59","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaad.2014.05.007_bib60","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary\u00a0artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib61","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"de Groot","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jaad.2014.05.007_bib62","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib63","first-page":"126","article-title":"American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome","volume":"11","year":"2005","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jaad.2014.05.007_bib64","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.steroids.2011.12.001","article-title":"Metabolic dysfunction in PCOS: Relationship to obstructive sleep apnea","volume":"77","author":"Ehrmann","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.jaad.2014.05.007_bib65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1210\/jc.2010-1187","article-title":"Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome","volume":"96","author":"Tasali","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2014.05.007_bib66","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.rmed.2010.01.010","article-title":"Effects of CPAP therapy on the sympathovagal balance and arterial stiffness in obstructive sleep apnea","volume":"104","author":"Shiina","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jaad.2014.05.007_bib67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/00365521.2010.539251","article-title":"Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)","volume":"46","author":"Hossain","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jaad.2014.05.007_bib68","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/humrep\/der197","article-title":"Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"26","author":"Barry","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jaad.2014.05.007_bib69","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/humupd\/dms029","article-title":"Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies","volume":"18","author":"Veltman-Verhulst","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jaad.2014.05.007_bib70","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/eje.1.02024","article-title":"Clinical and psychological correlates of quality-of-life in\u00a0polycystic ovary syndrome","volume":"153","author":"Hahn","year":"2005","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214014340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214014340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:32:08Z","timestamp":1759271528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214014340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0190962214014340"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.05.007","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovary syndrome: A review for dermatologists","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}